期刊文献+

雄激素与脂质代谢在前列腺癌细胞中的研究进展

Research Progress of Androgen and Lipid Metabolism in Prostate Cancer Cells
下载PDF
导出
摘要 前列腺癌是男性最常见的恶性肿瘤之一,大部分患者最终会发展为去势抵抗性前列腺癌,这一过程与雄激素及其受体介导的信号转导密切相关。另外,脂质代谢也与前列腺癌相关,胆固醇作为雄激素合成的前体物质,在合成雄激素过程中起关键作用。固醇调节元件结合蛋白(SREBPs)能够调节参与脂肪酸和胆固醇合成的相关基因表达,进而调控脂质生成并影响癌细胞脂质代谢,抑制前列腺癌细胞的增殖、迁移和侵袭。进一步研究SREBPs在前列腺癌细胞中的功能,探究前列腺癌脂质代谢与雄激素通路的相关机制,可能为前列腺癌的临床治疗提供更多思路。 Prostate cancer is one of the most common malignancies in men.A large proportion of the patients will eventually progress to castration-resistant prostate cancer due to drug resistance,which is closely related to signal transduction mediated by androgens and their receptors.In addition,lipid metabolism is also relevant in prostate cancer.As a precursor of androgen synthesis,cholesterol plays a key role in the process of androgen synthesis.Sterol regulator-binding proteins(SREBPs)can regulate the expression of genes involved in fatty acid and cholesterol synthesis,thus regulating lipid production and affecting the lipid metabolism of cancer cells,inhibiting the proliferation,migration and invasion of prostate cancer cells.Further studies on the function of SREBPs in prostate cancer cells and the mechanism of lipid metabolism and androgen pathway in prostate cancer may provide more ideas for the clinical treatment of prostate cancer.
作者 吕雪姣 李建辉 姜颖 LYU Xuejiao;LI Jianhui;JIANG Ying(School of Basic Medical College,Heilongjiang University of Chinese Medicine,Harbin 150040,China)
出处 《医学综述》 CAS 2023年第1期48-54,共7页 Medical Recapitulate
基金 国家自然科学基金(81804158) 黑龙江省自然科学基金(H2016074)。
关键词 前列腺癌 雄激素 脂质代谢 固醇调节元件结合蛋白 Prostate cancer Androgen Lipid metabolism Sterol regulatory element-binding proteins
  • 相关文献

参考文献7

二级参考文献100

  • 1杨念钦,王益鑫.激素非依赖性前列腺癌分子机制的研究现状[J].中华男科学杂志,2006,12(6):551-554. 被引量:4
  • 2宋海珠,陈龙邦.激素抵抗型前列腺癌的研究进展[J].中华男科学杂志,2007,13(1):57-60. 被引量:17
  • 3Mohler JL, Gregory CW, Ford OH 3rd, et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res, 2004, 10(2) : 440-448.
  • 4Attard G, Reid AH, Yap TA, et al. Phase I clinical trial of a se- lective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J Clin Oncol, 2008, 26(28) : 45634571.
  • 5Stanbrough M, Bubley GJ, Ross K, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen- independent prostate cancer. Cancer Res, 2006, 66 ( 5 ) : 2815- 2825.
  • 6Locke JA, Wasan KM, Nelson CC, et al. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A: Cholesterol acyltransferase (ACAT). Prostate, 2008, 68( 1): 20-33.
  • 7Auchus RJ. The backdoor pathway to dihydrotestostemne. Trends Endocfinol Metab, 2004, 15 (9) : 432-438.
  • 8Chang KH, Li R, Papari-Zareei M, et al. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant pros- tate cancer. Proc Natl Acad Sci USA, 2011, 108(33) : 13728- 13733.
  • 9Geller J, Albert JD, Nachtsheim DA, et al. Comparison of pros- tatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy. J Urol, 1984, 152 (4) : 693-696.
  • 10Platz EA, Clinton SK, Giovannucci E. Association between plas- ma cholesterol and prostate cancer in the PSA era. Int J Cancer, 2008, 123(7): 1693-1698.

共引文献281

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部